Bluebird -3% AH on $100M offering


Bluebird bio (BLUE) plans to sell $100M worth of shares through a public offering. Underwriters will have a $15M overallotment option.

The gene therapy developer had $192.5M in cash as of March 31, and no debt.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs